Kutlubay Z, Karakus Ö. Hair mesotherapy. Hair Ther Transplant. 2012;2:1–3.
Moftah N, Moftah N, Abd-Elaziz G, Ahmed N, Hamed Y, Ghannam B, Ibrahim M. Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation. J Eur Acad Dermatol Venereol. 2013;27:686–93. https://doi.org/10.1111/j.1468-3083.2012.04535.
Abdallah M, El-Zawahry K, Besar H. Mesotherapy using dutasteride-containing solution in male pattern hair loss: a controlled pilot study. PALD. 2009;20:137–45.
Sobhy N, Aly H, Shafee AE, Deeb MA. Evaluation of the effect of injection of dutasteride as mesotherapeutic tool in treatment of androgenetic alopecia in males. Our Dermatol Online. 2013;4:40–5.
Azam MH, Morsi HM. Comparative study between 2% minoxidil topical spray vs. intradermal injection (mesotherapy) for treatment of androgenetic alopecia in female patients: a controlled, 4-month randomized trial. EDOJ. 2010;6:1–12.
Chandrashekar BS, Sandeep MA, Vasanth V, Jagadish P, Rajashekar ML. Triamcinolone acetonide mesotherapy in the treatment of recalcitrant patches of alopecia areata – a pilot study. J Clin Dermatol Ther. 2015;2:006.
Konda D, Thappa DM. Mesotherapy: what is new? Indian J Dermatol Venereol Leprol. 2013;79:127–34.
Herreros FOC, Moraes AM, Velho PENF. Mesoterapia: uma revisão bibliográfica. An Bras Dermatol. 2011;86(1):96–101.
Sañudo A, Vallejo F, Sierra M, Hoyos JG, Yepes S, Wolff JC, et al. Nontuberculous mycobacteria infection after mesotherapy: preliminary report of 15 cases. Int J Dermatol. 2007;46:649–53.
Marco-Bonnet J, Beylot-Barry M, Texier-Maugein J, Barucq JP, Supply P, Doutre MS, Beylot C. Mycobacterial bovis BCG cutaneous infections following mesotherapy: 2 cases. Ann Dermatol Venereol. 2002;129:728–31.
Kadry R, Hamadah I, Al-Issa A, Field L, Alrabiah F. Multifocal scalp abscess with sub-cutaneous fat necrosis and scarring alopecia as a complication of scalp mesotherapy. J Drugs Dermatol. 2008;7:72–3.
Gungor S, Kocaturk E, Topal IO. Frontal edema due to topical application of %5 minoxidil solution following mesotherapy injections. Int J Trichol. 2015;7:86–7. https://doi.org/10.4103/0974-7753.160124.
Duque-estrada B, Vincenzi C, Misciali C, Tosti A. Alopecia secondary to mesotherapy. J Am Acad Dermatol. 2009;61:707–9. https://doi.org/10.1016/j.jaad.2008.11.896.
EL-Komy MHM, Hassan AS, Tawdy AM, Solimon MM, Hady MA. Hair loss at injection sites of mesotherapy for alopecia. J Cosmet Dermatol. 2017;16:e28–30.